Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-021728

EVP, R&D & Chief Scientific Of sold 18,327 shares at an average $39.79 ($729,265)

From the SEC's structured data for this filing

Trades in this filing

Haqq Christopher · EVP, R&D & Chief Scientific Of

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-26 Sale : show line 1 in the form −17,227 $39.76 $684,946 334,005 D
2018-03-26 Sale : show line 2 in the form −1,100 $40.29 $44,319 332,905 D
Open-market sales · 18,327 sh · avg $39.79 · $729,265
Loading xslF345X03/doc4.xml…